Mercado de soluciones clínicas electrónicas en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2030

Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado de soluciones clínicas electrónicas en Oriente Medio y África: tendencias de la industria y pronóstico hasta 2030

  • Pharmaceutical
  • Published Report
  • May 2023
  • MEA
  • 350 Páginas
  • Número de tablas: 77
  • Número de figuras: 43

Middle East And Africa Eclinical Solutions Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Diagram Período de pronóstico
2024 –2030
Diagram Tamaño del mercado (año base)
MILLONES DE DÓLARES
Diagram Tamaño del mercado (año de pronóstico)
USD 1,082.15
Diagram Tasa de crecimiento anual compuesta (CAGR)
%
Diagram Jugadoras de los principales mercados
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Mercado de soluciones clínicas electrónicas de Oriente Medio y África, por producto (sistemas de captura electrónica de datos y gestión de datos de ensayos clínicos, sistemas de gestión de ensayos clínicos, plataformas de análisis clínico, registros médicos de coordinación de atención (CCMR), gestión de suministro de ensayos y aleatorización, plataformas de integración de datos clínicos, soluciones de evaluación electrónica de resultados clínicos, soluciones de seguridad, sistemas de archivos maestros de ensayos electrónicos, soluciones de gestión de información regulatoria y otros), modo de entrega (soluciones alojadas en la web (a pedido), soluciones empresariales con licencia (en las instalaciones) y soluciones basadas en la nube (SAAS)), fase de ensayo clínico (fase I, fase II, fase III y fase IV), tamaño de la organización (pequeña, mediana y grande), dispositivo de usuario (computadora de escritorio, tableta, dispositivo PDA portátil, teléfono inteligente y otros), usuario final (compañías farmacéuticas y biofarmacéuticas, organizaciones de investigación por contrato, empresas de servicios de consultoría, fabricantes de dispositivos médicos, hospitales e institutos de investigación académica), tendencias de la industria y pronóstico hasta 2030.

Mercado de soluciones clínicas electrónicas en Oriente Medio y África

Análisis y tamaño del mercado de soluciones clínicas electrónicas en Oriente Medio y África

El mercado de soluciones clínicas electrónicas de Oriente Medio y África está fragmentado, ya que está formado por muchos actores globales como Oracle, IQVIA Inc., Dassault Systemes y Clario, entre otros. La presencia de estas empresas produce precios competitivos para servicios de sistemas y software en toda la región. Debido a la presencia de estos actores a nivel regional e internacional, los proveedores y fabricantes ofrecen productos con diferentes especificaciones y características para todos los presupuestos. La creciente adopción de sistemas de captura electrónica de datos (EDC) y basados ​​en la nube está impulsando el crecimiento del mercado. Además, se espera que el creciente enfoque en los ensayos clínicos centrados en el paciente impulse el crecimiento del mercado.

Mercado de soluciones clínicas electrónicas en Oriente Medio y ÁfricaMercado de soluciones clínicas electrónicas en Oriente Medio y África

Data Bridge Market Research analiza que se espera que el mercado de soluciones clínicas electrónicas de Oriente Medio y África alcance un valor de 1.082,15 millones de dólares en 2030, con una tasa de crecimiento anual compuesta (CAGR) del 11,9 % durante el período de pronóstico. Este informe de mercado también cubre en profundidad el análisis de precios y los avances tecnológicos.

Métrica del informe

Detalles

Período de pronóstico

2023 a 2030

Año base

2022

Años históricos

 2021 (Personalizable para 2015 – 2020)

Unidades cuantitativas

Ingresos en millones de USD, volúmenes en unidades y precios en USD

Segmentos cubiertos

Por producto (sistemas de captura electrónica de datos y gestión de datos de ensayos clínicos, sistemas de gestión de ensayos clínicos, plataformas de análisis clínico, registros médicos de coordinación de atención (CCMR), gestión de suministro de ensayos y aleatorización, plataformas de integración de datos clínicos, soluciones de evaluación electrónica de resultados clínicos, soluciones de seguridad, sistemas de archivos maestros de ensayos electrónicos, soluciones de gestión de información regulatoria y otros), modo de entrega (soluciones alojadas en la web (a pedido), soluciones empresariales con licencia (locales) y soluciones basadas en la nube (SAAS)), fase de ensayo clínico (fase I, fase II, fase III y fase IV), tamaño de la organización (pequeña, mediana y grande), dispositivo de usuario (computadora de escritorio, tableta, dispositivo PDA portátil, teléfono inteligente y otros), usuario final (compañías farmacéuticas y biofarmacéuticas, organizaciones de investigación por contrato, empresas de servicios de consultoría, fabricantes de dispositivos médicos, hospitales e institutos de investigación académica)

Países cubiertos

Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos, Egipto, Israel y el resto de Oriente Medio y África

Actores del mercado cubiertos

Los siguientes son algunos de los proveedores de servicios de salud que operan en el país: Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager, Datatrack Int. e IQVIA Inc.

 

Definición de mercado

El objetivo de las soluciones clínicas electrónicas es revolucionar el campo de la investigación clínica. La organización de gestión clínica está tratando de mejorar la eficacia, la eficiencia y la accesibilidad de los datos de investigación clínica para tratar a los pacientes más rápidamente. La idea detrás de la creación de las soluciones clínicas electrónicas era identificar los problemas con los datos de investigación clínica, solucionarlos y ofrecer soluciones creativas para hacer que los datos de los ensayos clínicos sean útiles y fáciles de obtener, así como para facilitar la estandarización, la elaboración de informes y el funcionamiento del ámbito de la investigación clínica. Se espera que la creciente adopción y el enfoque creciente en las soluciones y el software clínicos electrónicos impulsen el crecimiento del mercado.

 Las soluciones clínicas electrónicas, como la captura electrónica de datos (EDC), los resultados informados por los pacientes de forma electrónica (ePRO), los sistemas de gestión de ensayos clínicos (CTMS) y los sistemas de archivo maestro de ensayos electrónicos (eTMF), son programas informáticos que se utilizan en la investigación clínica para gestionar los datos clínicos. Sin embargo, se espera que las estrictas normas y regulaciones para la aprobación de estudios de ensayos clínicos y de productos limiten el crecimiento del mercado.

Dinámica del mercado de soluciones clínicas electrónicas en Oriente Medio y África

En esta sección se aborda la comprensión de los factores impulsores, las oportunidades, las limitaciones y los desafíos del mercado. Todo esto se analiza en detalle a continuación:

CONDUCTORES

Aumentar las actividades de I+D y el gasto correspondiente

Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.

The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.

Improved healthcare infrastructure and establishment of advanced laboratories

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.

Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.

OPPORTUNITY

 Increasing investments by various governments in clinical trials

Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.

RESTRAINT / CHALLENGE

Data Safety and Privacy issues

Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.

Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the Middle East and Africa e-clinical solutions market and is expected to hamper market growth.

Post-COVID-19 Impact on the Middle East and Africa e-Clinical Solutions Market

COVID-19 positively impacted the Middle East and Africa e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.

However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth has been high since the market opened after COVID-19, and it is expected that there will be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.

Recent Developments

  • In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
  • In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering

Middle East and Africa e-Clinical Solutions Market Scope

The Middle East and Africa e-clinical solutions market is segmented into six notable segments based on product, delivery mode, clinical trial phase, organization size, user device, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Product

  • Electronic Data Capture and Clinical Data Management Systems
  • Clinical Trial Management Systems
  • Clinical Analytics Platforms
  • Care Coordination Medical Record (CCMR)
  • Randomization and Trial Supply Management
  • Clinical Data Integration Platforms
  • Electronic Clinical Outcome Assessment Solutions
  • Safety Solutions
  • Electronic Trial Master File  Systems
  • Regulatory Information Management Solutions
  • Others

Based on product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems,  clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions and others.

Delivery Mode

  • Web-Hosted (On-Demand) Solutions
  • Licensed Enterprise (On-Premises) Solutions
  • Cloud-based (SAAS) Solutions

Based on delivery mode, the market is segmented into web-hosted (on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.

Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Based on clinical trial phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.

Organization Size

  • Small & Medium
  • Large

Based on organization size, the market is segmented into small & medium, and large.

User Device

  • Desktop
  • Tablet
  • Handheld PDA Device
  • Smart Phone
  • Others

Based on user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.

End User

  • Pharmaceutical and Biopharmaceutical companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutes

Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.

Mercado de soluciones clínicas electrónicas

Middle East and Africa e-Clinical Solutions Market Regional Analysis/Insights

The Middle East and Africa e-clinical solutions market is analyzed, and market size information is p based on product, delivery mode, clinical trial phase, organization size, user device, and end user.

The countries covered in this market report are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and the Rest of the Middle East and Africa.

Se espera que Sudáfrica domine la región de Medio Oriente y África debido a la creciente adopción de sistemas de captura electrónica de datos y soluciones basadas en la nube.

La sección de países del informe también proporciona factores individuales que impactan en el mercado y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, leyes regulatorias y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas de Asia-Pacífico y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales y el impacto de los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de las soluciones clínicas electrónicas en Oriente Medio y África

El panorama competitivo del mercado de soluciones clínicas electrónicas de Oriente Medio y África proporciona detalles sobre los competidores. Los detalles incluyen una descripción general de la empresa, información financiera, ingresos generados, potencial de mercado, nuevas iniciativas de mercado, presencia global, sitios e instalaciones de producción, capacidades de producción, fortalezas y debilidades de la empresa, lanzamiento de productos, amplitud y variedad de productos y dominio de aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Algunos de los principales actores del mercado que operan en el mercado de soluciones clínicas electrónicas de Medio Oriente y África son Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC y RealTime Software Solutions, entre otros.


SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER'S FIVE FORCES MODEL

4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS

4.3 USE CASES

5 VALUE CHAIN ANALYSIS

6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS

7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE

7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES

7.2 RESTRAINTS

7.2.1 DATA SAFETY AND PRIVACY ISSUES

7.2.2 LACK OF SKILLED PROFESSIONALS

7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES

7.3 OPPORTUNITIES

7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS

7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS

7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS

7.4 CHALLENGES

7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS

7.4.2 HIGH IMPLEMENTATION COSTS

8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS

8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT

8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS

8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS

8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS

8.7 SAFETY SOLUTIONS

8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS

8.9 CLINICAL DATA INTEGRATION PLATFORMS

8.1 CLINICAL ANALYTICS PLATFORMS

8.11 CARE COORDINATION MEDICAL RECORD (CCMR)

8.12 OTHERS

9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE

9.1 OVERVIEW

9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS

9.3 CLOUD-BASED (SAAS) SOLUTIONS

9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS

10 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

10.1 OVERVIEW

10.2 PHASE III

10.3 PHASE I

10.4 PHASE II

10.5 PHASE IV

11 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE

11.1 OVERVIEW

11.2 MEDIUM AND SMALL

11.3 LARGE

12 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE

12.1 OVERVIEW

12.2 DESKTOP

12.3 TABLET

12.4 SMART PHONE

12.5 HANDHELD PDA DEVICE

12.6 OTHERS

13 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER

13.1 OVERVIEW

13.2 CONTRACT RESEARCH ORGANIZATIONS

13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

13.4 MEDICAL DEVICE MANUFACTURERS

13.5 HOSPITAL

13.6 CONSULTING SERVICE COMPANIES

13.7 ACADEMIC RESEARCH INSTITUTES

14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY REGION

14.1 MIDDLE EAST AND AFRICA

14.1.1 SOUTH AFRICA

14.1.2 SAUDI ARABIA

14.1.3 U.A.E.

14.1.4 EGYPT

14.1.5 ISRAEL

14.1.6 REST OF MIDDLE EAST AND AFRICA

15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 ORACLE

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENT

17.2 DASSAULT SYSTEMES

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENTS

17.3 CLARIO

17.3.1 COMPANY SNAPSHOT

17.3.2 COMPANY SHARE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENT

17.4 VEEVA SYSTEMS

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENTS

17.5 ARISMIDDLE EAST & AFRICA

17.5.1 COMPANY SNAPSHOT

17.5.2 COMPANY SHARE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENTS

17.6 4G CLINICAL

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 ADVARRA.

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 ANJU

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENTS

17.9 CASTOR.

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 DATATRAK INT.

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 ECLINICAL SOLUTIONS LLC.

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 IQVIA INC

17.12.1 COMPANY SNAPSHOT

17.12.2 REVENUE ANALYSIS

17.12.3 PRODUCT PORTFOLIO

17.12.4 RECENT DEVELOPMENTS

17.13 MAXISIT

17.13.1 COMPANY SNAPSHOT

17.13.2 PRODUCT PORTFOLIO

17.13.3 RECENT DEVELOPMENT

17.14 MEDNET

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENT

17.15 MEDRIO, INC.

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENTS

17.16 MERATIVE

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENT

17.17 OPENCLINICA, LLC

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENT

17.18 PAREXEL INTERNATIONAL CORPORATION

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENT

17.19 QURETEC

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENT

17.2 REALTIME SOFTWARE SOLUTIONS, LLC

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

17.21 RESEARCH MANAGER

17.21.1 COMPANY SNAPSHOT

17.21.2 PRODUCT PORTFOLIO

17.21.3 RECENT DEVELOPMENT

17.22 SAAMA TECHNOLOGIES, LLC

17.22.1 COMPANY SNAPSHOT

17.22.2 PRODUCT PORTFOLIO

17.22.3 RECENT DEVELOPMENT

17.23 SIGNANT HEALTH

17.23.1 COMPANY SNAPSHOT

17.23.2 PRODUCT PORTFOLIO

17.23.3 RECENT DEVELOPMENT

17.24 Y-PRIME, LLC.

17.24.1 COMPANY SNAPSHOT

17.24.2 PRODUCT PORTFOLIO

17.24.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

Lista de Tablas

TABLE 1 THE COSTS OF IMPLEMENTATION ARE AS FOLLOWS, ACCORDING TO SIMPLETRIALS:

TABLE 2 ACCORDING TO ECLINICAL WORKS – ECLINICAL OFFERS TWO ENTERPRISE PRICING PACKAGES:

TABLE 3 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA CLINICAL TRIAL MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA ELECTRONIC TRIAL MASTER FILE SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA SAFETY SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA CLINICAL DATA INTEGRATION PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA CLINICAL ANALYTICS PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA CARE COORDINATION MEDICAL RECORD (CCMR) IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA WEB-HOSTED (ON-DEMAND) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA CLOUD-BASED (SAAS) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PHASE III IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA PHASE I IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA PHASE II IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA PHASE IV IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA MEDIUM AND SMALL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA LARGE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA DESKTOP IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA TABLET IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA SMART PHONE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA HANDHELD PDA DEVICE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HOSPITAL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA CONSULTING SERVICE COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA ACADEMIC RESEARCH INSTITUTES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 47 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 48 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 49 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 50 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 51 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 52 SOUTH AFRICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 53 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 54 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 55 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 56 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 57 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 58 SAUDI ARABIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 59 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 60 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 61 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 62 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 63 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 64 U.A.E. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 65 EGYPT E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 66 EGYPT E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 67 EGYPT E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 68 EGYPT E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 69 EGYPT E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 70 EGYPT E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 71 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 72 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)

TABLE 73 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)

TABLE 74 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)

TABLE 75 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)

TABLE 76 ISRAEL E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 77 REST OF MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

Lista de figuras

FIGURE 1 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA E- CLINICAL SOLUTIONS MARKET: SEGMENTATION

FIGURE 11 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS AS WELL AS INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE, IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA E- CLINICAL SOLUTIONS MARKET FROM 2023 TO 2030

FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET IN 2023 AND 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET

FIGURE 14 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2022

FIGURE 15 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2022

FIGURE 19 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2023-2030 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, CAGR (2023-2030)

FIGURE 21 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2022

FIGURE 23 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2023-2030 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, CAGR (2023-2030)

FIGURE 25 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2022

FIGURE 27 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2023-2030 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, CAGR (2023-2030)

FIGURE 29 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2022

FIGURE 31 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2023-2030 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, CAGR (2023-2030)

FIGURE 33 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, LIFELINE CURVE

FIGURE 34 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2022

FIGURE 35 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 36 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 37 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: BY END USER, LIFELINE CURVE

FIGURE 38 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)

FIGURE 39 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)

FIGURE 40 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 41 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)

FIGURE 42 MIDDLE EAST AND AFRICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)

FIGURE 43 MIDDLE EAST & AFRICA E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The Middle East and Africa e-Clinical Solutions Market is projected to grow at a CAGR of 11.9% during the forecast period by 2030.
The future market value of the Middle East and Africa e-Clinical Solutions Market is expected to reach USD 1,082.15 million by 2030.
The major players in the Middle East and Africa e-Clinical Solutions Market are Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, etc.
The countries covered in the Middle East and Africa e-Clinical Solutions Market are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and the Rest of the Middle East and Africa.